Tango Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 07, 2023 at 07:57 am EDT
Tango Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 14.6 million compared to USD 5.77 million a year ago. Net loss was USD 20.71 million compared to USD 24.86 million a year ago. Basic loss per share from continuing operations was USD 0.23 compared to USD 0.28 a year ago.
For the six months, revenue was USD 20.36 million compared to USD 11.53 million a year ago. Net loss was USD 48.72 million compared to USD 50.07 million a year ago. Basic loss per share from continuing operations was USD 0.55 compared to USD 0.57 a year ago.